Feike Jeffrey L. 4
4 · Tevogen Bio Holdings Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Feike Jeffrey L.
Director
Transactions
- Award
Common Stock
2024-02-14+581,771→ 581,771 total
Footnotes (1)
- [F1]On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc ("Tevogen"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer.